Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2023 | Using single-cell sequencing to define mechanisms of progression from SMM to myeloma

In this video, Irene Ghobrial, MD, Dana-Farber Cancer Institute, Boston, MA, briefly discusses how single-cell sequencing (SCS) may be used to better understand disease progression from smoldering multiple myeloma (SMM) to active myeloma and mechanisms of resistance to immunotherapies. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.